Natural Dietary Supplement of Reindeer Antlers

Manufacturer of Natural Dietary Supplement of Reindeer Antlers

"PLANETA ZDOROVYA" offers delivery of our products in Sudan.

CigaPan® was re-registered in accordance with the requirements of technical

regulations of the Customs Union 021\2011, 022/2011
the certificate of state registration №RU.77.99.88.003.Е.000362.01.16 from
28.01.2016г.

.
CigaPan® previously registered in: Belarus, Ukraine, Kazakhstan,
Armenia, Uzbekistan, Lithuania, Latvia, USA, Germany, Austria, Czech
Republic, Bulgaria, Vietnam, etc.
Over 20 years of sales, won the trust and commitment of millions, not only
Russian but also foreign buyers.
for children from 3 years
Tablets 200mg №60

for children over 12 and

adults Сapsules 400
mg №60, №120
 Unique Russian development
20 years!

 Over 100 scientific studies!

 A broad action spectrum - 263 areas!
 49 leading
. Russian research institutes have studied options of its
application!
 Over 200 members of the Academy of Sciences, Doctors and
Candidates of Sciences have participated in the research
process!
 It has been listed in the Book of Planet Records and the Book of
Russian Records!
CigaPan® - 100% natural ingredients:
powder of reindeer antlers.
Contains a .complex of biologically active components: a large set of micro- and
macro-elements, vitamins, a wide range of amino acids, biologically active
peptides, phospholipids.
 has a systemic strengthening effect on the body
 promotes the increase of vitality and working capacity
 has a manifest anti-oxidant activity
 ensures .the growth of adaptogenic resources
 promotes normalization of metabolism
 assists in improving the functional condition of the endocrine,
cardiovascular, urogenital systems and the gastrointestinal tract
 Numerous scientific, pre-clinical and
clinical trials* have demonstrated that
CigaPan® promotes:
• increase of the immunobiological and defensive capacity of the body;
• normalizing the metabolic effect (activity);
• regulation of oxidation-reduction processes, hematopoiesis processes,
endocrine gland function;
• restoration of. the hormonal balance;
• normalizing the mineral metabolism, including in case of osteoporosis;
• strengthening and development of the osseous and muscular tissue and
acceleration of its recovery after traumas and fractures;
• rapid regeneration of damaged tissues (wounds and burns);
• has geroprotective action (decelerates the ageing process of the body);
• improves the reproductive function;
• stimulates the sexual function in adults;
• has positive influence on the functional condition of liver;
 Numerous scientific, pre-clinical and
clinical trials* have demonstrated that
CigaPan® promotes:

• has detoxificatin action (promotes excretion of toxins, heavy metals and

radionuclides from the body);
• reduces side effects of radiation and chemotherapy;
• increases the psychological and emotional resistance;
.
• increases physical activity and endurance;
• accelerates recovery after intensive work, heavy physical and mental exertion;
• assists in rapid restoration of the body’s functions under extreme factors,
prolonged stress;
• accelerates rehabilitation processes;
• lengthens the remission period of chronic diseases;
• reduces the risk of disease development.
 The use of CigaPan® simultaneously with the principal therapy
allows increasing effectiveness of treatment of various diseases*,
protecting from side effects of medication and reducing the
treatment period. Increases the remission period of chronic
diseases.
.

 CigaPan® is not toxic, antimutagenic, has no side effects.

Assessment of CigaPan’s potential of causing toxic effects and
adverse long-term effects (mutagenic, etc.) has demonstrated
complete safety of its use.
CURRENTLY, CIGAPAN® IS ONE OF THE MOST
WELL-RESEARCHED AND CLINICALLY
STUDIED DIETARY SUPPLEMENTS.
ASSESSMENT OF CLINICAL EFFECTIVENESS OF CIGAPAN® IN COMPLEX THERAPY OF THE FOLLOWING
CONDITIONS IN ADULTS HAS BEEN PERFORMED*:
*metabolic syndrome (with a high risk of development of cardiovascular diseases and Type 2 diabetes melli-
tus); Type I and II diabetes mellitus; Stage 1-2 hypertensive disease with associated obesity (accompanied by
a reduced-calorie, low-sodium, hypolipodermic, anti-atherosclerotic diet); ischemic heart disease (IHD); Stge
I-II diffuse enlargement of the thyroid gland, hyperfunction, endocrinous ophthalmopathy; hypofunction of
the thyroid gland; chronic destructive and inflammatory diseases of the gastrointestinal tract (gastric and
duodenal ulcer disease,. gastritis); hepatitis В and С; enteroviral infection; dysfunction of the urogenital sys-
tem (impotence, chronic prostatitis, testicular hypofunction, oligozoospermia, asthenozoospermia, decrease
of erection quality, lowered libido); tuberculosis, including accompanied by Type 2 diabetes mellitus; lympho-
granulomatosis; during the period of clinical hematological compensation in patients suffering from
thrombo-cytopenia (ITP); hemophilia and patients with an intact blood-clotting system; osteoporosis,
musculoskeletal traumas, including fractures; gunshot wounds; conditions related to psychological and
physical stresses: in extreme conditions, when special forces officers perform their tactical missions, for
athletes of higher and top qualification; neurological diseases accompanied by degenerative and dystrophic
as well as painful symptoms; acute psychopharmacological drug, narcotic substance, carbon monoxide
poisoning; asthenic, weakened patients as well as drug addicts as a supplementary substance easing
withdrawal symptoms as well as during the remission stage; people subjected to ionizing radiation due to the
nature of their activities or those residing at radiation-contaminated territories as a result of a nuclear
disaster; nursing mothers residing in environmentally unfavorable regions.
* Based on the data of clinical studies performed by the Scientific and Research Institute of
Neurology of the Russian Academy of Sciences, State Scientific and Research Center of
Preventive Medicine of the Ministry of Public Health of Russia, Scientific and Research Institute of
Nutrition of the Russian Academy of Medical Sciences, Russian Scientific and Research Institute
of Physical Education and Sports, Federal Scientific and Medical Center of Medical Sexology and
Sexopathology of the Scientific and Research Institute of Psychiatry, Medical Radiological
Scientific Center of the Russian Academy of Medical Sciences, Hematological Scientific Center of
.
the Russian Academy of Medical Sciences, Main Military Clinical Hospital of Internal Troops of the
Ministry of Internal Affairs of Russia, Medical Scientific and Research Institute of Pediatrics and
Pediatric Surgery of the Ministry of Public Health of Russia, N.V. Sklifosovsky’s Scientific and
Research Institute of Emergency Care, Central Scientific and Research Institute of Tuberculosis
Studies, Clinic of the Russian Scientific and Re-search Center of Gerontology, Postgraduate
Professional Education Department of I.M. Sechenov’s Moscow Medical Academy, EFiS Scientific
Center, Neurological Department of the Saint Petersburg Clinical Hospital of the Russian Academy
of Sciences, Russian Scientific Center of Radiology and Nuclear Medicine of the Ministry of Public
Health of Russia, Scientific and Research Institute of Influenza Studies of the Russian Academy of
Medical Sciences, Municipal Health-Care Institution “Volskaya Children’s Hospital” of the Ministry
of Public Health of Russia, OMON of the Main Administration of Internal Affairs of Moscow.
EFFECTIVENESS AND SAFETY OF USING CIGAPAN® IN THE
PEDIATRIC PRACTICE HAVE BEEN CONFIRMED BY SPECIAL
STUDIES IN THE COURSE OF COMPLEX TREATMENT OF*:

*bronchial asthma; dysfunctions of the gastrointestinal tract, including Stage 2-3

dysbacteriosis; vagotonic vegetative-vascular dystonia; genetic osteoporosis caused by
hereditary disruptions of phosphorus-potassium metabolism (rickets-like diseases),
connective tissue diseases, osteopathies; atopical dermatitis; children suffering from the
nephritic form of glomerulonephritis undergoing long-term prednisolone treatment;
pathologies caused by the residence at radiation contaminated territories; childhood
.
microelementosis in children residing in environmentally unfavorable regions.

*Studies conducted at the Medical Scientific and Research Institute of Pediatrics and Pediatric
Surgery of the Ministry of Public Health of Russia and Municipal Health-Care Institution “Volskaya
Children’s Hospital” of the Ministry of Public Health of Russia.
•
More information on the website

www.cigapan.ru